The aim of this study was to evaluate the inhibition of 2-HG by comparing 2-HG concentrations in excised and untreated control tumors of IDH1 mutant glioma subjects treated with AG-120 or AG-881 (non-specific IDH inhibitors). The gene discussed is IDH1; the disease is central nervous system cancer.